Skip to main content
Top
Published in: Medical Oncology 3/2018

01-03-2018 | Original Paper

Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections

Authors: Daniel E. Spratt, Krithika Suresh, Takahiro Osawa, Matthew Schipper, William C. Jackson, Ahmed Abugharib, Amir Lebastchi, David Smith, Jeffrey S. Montgomery, Ganesh S. Palapattu, L. Priya Kunju, Angela Wu, Madelyn Lew, Scott A. Tomlins, Arul M. Chinnaiyan, Alon Z. Weizer, Khaled S. Hafez, Samuel D. Kaffenberger, Aaron Udager, Rohit Mehra

Published in: Medical Oncology | Issue 3/2018

Login to get access

Abstract

The frequency of co-occurrence between germ cell tumor (GCT) components in non-seminomatous germ cell tumor (NSGCT) orchiectomy specimens and their correlation with histologic findings in subsequent retroperitoneal lymph node dissection (RPLND) specimens have not been well characterized. The objective of the study was to report the first detailed clinicopathologic analysis of NSGCT orchiectomy and RPLND samples to determine the likelihood and agreement of the co-occurrence of GCT components. A total of 118 consecutive patients with NSGCT treated between 1988 and 2012 who underwent both orchiectomy and RPLND at a single academic tertiary care center were analyzed. Statistical analysis of co-occurrence likelihood and agreement of GCT components was performed, both within and between orchiectomy and RPLND specimens. Embryonal carcinoma was the most frequent component present in orchiectomy specimens, and there were multiple significant associations between orchiectomy GCT components; seminoma occurred less frequently with embryonal carcinoma (OR 0.29 [95% confidence interval (CI) 0.11–0.75]; p < 0.01), and teratoma more frequently occurred with choriocarcinoma (OR 9.64 [95% CI 1.22–76.12]; p = 0.01). Presence of teratoma in the orchiectomy specimen predicted for a fourfold increase in distant metastasis on multivariate analysis (HR 4.92 [1.14–18.9]; p = 0.02). The only significant association of co-occurrence in the RPLND specimen was between embryonal carcinoma and teratoma (OR 0.01 [95% CI 0–0.07]; p < 0.001), where it was significantly less likely for them to occur together. Our findings are limited by their retrospective nature. The co-occurrence of GCT components within orchiectomy specimens does not appear to be a completely random process. However, there is less agreement and more randomness between the occurrence of the GCT components in matched orchiectomy and RPLND samples. In this report, we look at the co-occurrence of different GCT components within matched orchiectomy and RPLND pathology specimens and show that co-occurrence is not a completely random process.
Appendix
Available only for authorised users
Literature
1.
go back to reference McGlynn KA, Cook MB. Etiologic factors in testicular germ cell tumors. Future Oncol (Lond Engl). 2009;5(9):1389–402.CrossRef McGlynn KA, Cook MB. Etiologic factors in testicular germ cell tumors. Future Oncol (Lond Engl). 2009;5(9):1389–402.CrossRef
3.
go back to reference Ghazarian AA, Trabert B, Devesa SS, McGlynn KA. Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology. 2015;3(1):13–8.CrossRefPubMed Ghazarian AA, Trabert B, Devesa SS, McGlynn KA. Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology. 2015;3(1):13–8.CrossRefPubMed
4.
go back to reference Tu S-M, Bilen MA, Hess KR, et al. Intratumoral heterogeneity: role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer. 2016;122(12):1836–43.CrossRefPubMedPubMedCentral Tu S-M, Bilen MA, Hess KR, et al. Intratumoral heterogeneity: role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer. 2016;122(12):1836–43.CrossRefPubMedPubMedCentral
5.
go back to reference Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch Pathol Lab Med. 2007;131(8):1267.PubMed Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch Pathol Lab Med. 2007;131(8):1267.PubMed
6.
go back to reference Kundu SD, Feldman DR, Carver BS, et al. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors. J Urol. 2015;193(2):513–8.CrossRefPubMed Kundu SD, Feldman DR, Carver BS, et al. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors. J Urol. 2015;193(2):513–8.CrossRefPubMed
7.
go back to reference Sheinfeld J, Motzer RJ, Rabbani F, McKiernan J, Bajorin D, Bosl GJ. Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors. J Urol. 2003;170(4):1159–62.CrossRefPubMed Sheinfeld J, Motzer RJ, Rabbani F, McKiernan J, Bajorin D, Bosl GJ. Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors. J Urol. 2003;170(4):1159–62.CrossRefPubMed
8.
go back to reference Freedman LS, Jones WG, Peckham MJ, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 1987;330(8554):294–8.CrossRef Freedman LS, Jones WG, Peckham MJ, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet. 1987;330(8554):294–8.CrossRef
9.
go back to reference McKendrick JJ, Theaker J, Mead GM. Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin. Cancer. 1991;67(3):684–9.CrossRefPubMed McKendrick JJ, Theaker J, Mead GM. Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin. Cancer. 1991;67(3):684–9.CrossRefPubMed
10.
go back to reference Al-Ahmadie HA, Carver BS, Cronin AM, et al. Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy. Urology. 2013;82(6):1341–7.CrossRefPubMed Al-Ahmadie HA, Carver BS, Cronin AM, et al. Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy. Urology. 2013;82(6):1341–7.CrossRefPubMed
11.
go back to reference Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5(3):210–22.CrossRefPubMed Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5(3):210–22.CrossRefPubMed
12.
go back to reference Chéry L, Dash A. The role of postchemotherapy surgery in germ cell tumors. Urol Clin North Am. 2015;42(3):331–42.CrossRefPubMed Chéry L, Dash A. The role of postchemotherapy surgery in germ cell tumors. Urol Clin North Am. 2015;42(3):331–42.CrossRefPubMed
Metadata
Title
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections
Authors
Daniel E. Spratt
Krithika Suresh
Takahiro Osawa
Matthew Schipper
William C. Jackson
Ahmed Abugharib
Amir Lebastchi
David Smith
Jeffrey S. Montgomery
Ganesh S. Palapattu
L. Priya Kunju
Angela Wu
Madelyn Lew
Scott A. Tomlins
Arul M. Chinnaiyan
Alon Z. Weizer
Khaled S. Hafez
Samuel D. Kaffenberger
Aaron Udager
Rohit Mehra
Publication date
01-03-2018
Publisher
Springer US
Published in
Medical Oncology / Issue 3/2018
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-018-1090-y

Other articles of this Issue 3/2018

Medical Oncology 3/2018 Go to the issue